-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OtnStHTPenb/CMKrF6foU5xf+HNraXaQh6gdx3/9LoMt1u7fgJ+tdmvhRf4kinx8 YFATad8CD4RyoGUGJRy6bw== 0000917520-05-000035.txt : 20050211 0000917520-05-000035.hdr.sgml : 20050211 20050211155545 ACCESSION NUMBER: 0000917520-05-000035 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041115 FILED AS OF DATE: 20050211 DATE AS OF CHANGE: 20050211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 C ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 311 C ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARLOZZI GERARD S CENTRAL INDEX KEY: 0001265180 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 05598514 BUSINESS ADDRESS: STREET 1: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 BUSINESS PHONE: 6092750500 4/A 1 gcform4111604amended_ex.xml X0202 4/A 2004-11-15 2004-11-18 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001265180 CARLOZZI GERARD S 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 0 1 0 0 Executive VP/COO Incentive Stock Option (right to buy) 35.52 2004-11-15 4 A 0 118 0 A 2010-11-15 Common Stock 118 118 D Non-Qualified Stock Option (right to buy) 35.52 2004-11-15 4 A 0 24882 0 A 2010-11-15 Common Stock 24882 24882 D 25% of the combined Incentive Stock Options and Non-Qualified Stock Options set forth in Table II vest one year after the grant date, with the remaining 75% vesting monthly thereafter over 36 months. Note: On the Form 4 originally filed, the two option grants set forth in Table II above were aggregated on one line in Table II and inadvertently included in Table I as well. This amendment is being filed to remove the securities from Table I and to separate the two different grants in Table II. /s/ Gerard S. Carlozzi 2005-02-09 -----END PRIVACY-ENHANCED MESSAGE-----